Biocon Certifies ₹200 Crore Commercial Paper Compliance

• Biocon Limited submitted a quarterly SEBI compliance certificate for its Commercial Paper (CP) issuances for the quarter ended March 31, 2026.
• The company certified that ₹200 crore worth of CPs issued in the calendar year were utilized for acquiring equity and redeeming debentures in subsidiaries.
• The company confirmed adherence to all listing conditions, a 'Standard' asset classification, and no material adverse change affecting its credit rating.
• Both CPs, with a total face value of ₹2,000 crore, were fully bought back and payment obligations were fulfilled on January 30, 2026.